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1. Introduction 
Hypoglycaemia is a problem caused by insulin treatment. It can lower 
the blood glucose level in insulin-treated diabetic patients. It is fundamental 
for diabetes patients to be able to recognise their own symptoms quickly to 
prevent more severe problems before restorative action can be taken. Among 
the most prominent symptoms are sweating, trembling, difficulty 
concentrating, nervousness and dizziness. Symptoms have also been sub-
divided into groups: Hepburn et al. (1992) classified symptoms developed 
from lack of glucose in brain as neuroglycopenic symptoms and symptoms 
that happen unconsciously resulting from the nervous system's response to 
hypoglycaemia as autonomic symptoms. Deary (1993) added a “general 
malaise” group to the two previous groups. Many studies show that 
symptoms of hypoglycaemia vary considerably among patients (Cox et al, 
1993), but symptom variability for individual patients has attracted less 
attention. 
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Zammitt et al. (2011) developed a statistical model quantifying 
individual differences in symptom reporting and found that adults exhibit 
distinct intra-individual variability in symptom reporting. This is important 
in educating patients with diabetes as they should be aware that symptoms 
vary not only between individuals but also between hypoglycaemic episodes 
of an individual. 
 
In this paper we build on work in Zammitt et al. (2011) to allow for 
different forms of symptom experiencing thresholds and consider between-
group variability when symptoms are classified in groups. We also extend 
the investigation of the impact of patient-specific factors on symptom 
consistency by including certain interactions among these factors, and 
determine the best predictive model by performing variable selection.  
 
2. Data 
Data were collected during a study conducted in several health centres 
in the UK. The data were collected from 381 participants, aged between 17-
75 years old and this study involved adult participants with age range, 22-74 
years.Provided information includes all hypoglycaemic episodes experienced 
(see Table 1) with time, date, duration, symptoms, treatment received (oral 
or injection) and concurrent blood glucose. Episodes occurring within 24 
hours of the preceding episode are considered to have diminished intensity. 
Thus, those episodes were excluded from the present work. 
 
The analysis includes 59 subjects as we only included subjects who 
experienced at least two hypoglycaemic episodes per month. Therefore, only 
patients with 19 or more episodes were considered for further analysis. The 
study also collected information on the following 10 patient-specific factors: 
age, gender, body mass index (BMI), type of diabetes, duration of diabetes, 
retinopathy, awareness of hypoglycaemia, stimulated C-peptide, hemoglobin 
A1c, and serum angiotensin converting enzyme activity (ACE). Retinopathy 
is an eye disease in the retina which acts as a marker for lack of glucose. C-
peptide is a protein that acts as insulin precursor and links directly with 
insulin secretion. Therefore, by measuring the amount of C-peptide in blood, 
we will also know the insulin level of a patient. HaemoglobinA1c measures 
how much sugar is bound to haemoglobin, and high haemoglobinA1c test 
indicates high glucose level. Diabetic patients have higher than normal 
serum angiotensin converting enzyme level. This protein relates to blood 
pressure control. 
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TABLE 1: List of Symptoms on Patients’ Report Form and The Group Categorisation 
No. Symptom Group No. Symptom Group 
1 Confussion Neuroglycopenic 14 Blurred vision Neuroglycopenic 
2 Sweating Autonomic 15 Hunger Autonomic 
3 Drowsiness Neuroglycopenic 16 Thirst Autonomic 
4 Weakness Neuroglycopenic 17 Nausea General Malaise 
5 Dizziness Neuroglycopenic 18 Anxiety Autonomic 
6 Feeling warm Autonomic/Neurogly
copenic 
19 Tiredness Neuroglycopenic 
7 Difficulty speaking Neuroglycopenic 20 Tingling Autonomic 
8 Pounding heart Autonomic 21 Trembling Autonomic 
9 Impaired concentration Neuroglycopenic 22 Headache General Malaise 
10 Shivering Autonomic 23 Malaise General Malaise 
11 Unsteady Neuroglycopenic 24 Irritability Autonomic/Neuroglycop
enic 
12 Nonspecific awareness Other 25 Other Other 
13 Double vision Neuroglycopenic 26 None No symptoms 
      
 
3. Model For Patient Consistency 
Following Zammitt et al. (2011), we model the intra-individual 
consistency using a logistic-type latent variable model. Latent variables are 
used to represent the propensity of symptoms and intensity of episodes as 
these cannot be observed directly and need to be estimated through 
observation of symptoms and episodes of hypoglycaemia. 
 
To assess consistent reporting across episodes for each subject, we 
present the symptoms and episodes of the patient in a matrix form with J × 
K dimension, where J = number of symptoms and K = number of episodes. 
This is illustrated in Figure 1, where the frequency of a symptom reported by 
a patient represents the symptom’s propensity and the intensity of an episode 
is represented by the number of symptoms occurring during that particular 
episode. 
 
We consider the random indicator variable, Yijk~ Bernoulli(pijk)taking 
value 1 for patient i reporting symptom j at episode k (and 0 otherwise), 
where pijk is the corresponding probability of “success”. Patient i reports 
symptom j at episode k when h(αij,βik) exceeds a random threshold assigned 
to each patient, where αij represents the propensity of symptom j for 
individual i, βik  represents the intensity of episode k for individual iand h() is 
an appropriate functional form. The propensity of a symptom refers to the 
tendency for a patient to report that particular symptom, whereas intensity of 
an episode corresponds to how intense the episode is, with more symptoms 
experienced in an episode implying higher intensity. The random threshold 
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assigned to each patient, denoted by τijk is assumed to follow a log-normal 
distribution, i.e. 𝜏𝑖𝑗𝑘 ~ 𝑁(0, 𝜎𝑖
2). Thus, the probability of patient i reporting 
symptom j in episode k, is given by 
 
𝑝𝑖𝑗𝑘  = Pr (𝜏𝑖𝑗𝑘 ≤  ℎ(𝛼𝑖𝑗 , 𝛽𝑖𝑘)) =  Φ (
log  {ℎ(𝛼𝑖𝑗 , 𝛽𝑖𝑘)}
𝜎𝑖
) 
 
where Φ() is the cumulative distribution function of a standard normal 
variable. Under a Bayesian framework, we also specify appropriate prior 
distributions for the model parameters αij, βik and σi. In this analysis, we 
assume independent priors for the latent variables with αij~ 
Gamma(aα,bα)and βik  ~ Gamma(aβ,bβ) where aα= aβ = 1 and bα = bβ = 0.1. 
We also assign a relatively vague inverse-gamma prior distribution to the 
variance parameter, σi
2
  ~Inv-Gamma(γσ,δσ) for i=1,…,59 where γσ = 1 and 
δσ= 0.1. 
 
Parameter σi measures the symptom-reporting consistency of a patient. 
A rescaled consistency parameter is used for easier interpretation, given as ci 
= 100/(1+ σi
2
) where 𝑐𝑖  ∈ (0,100] . A large ci value indicates high 
consistency. Note that for large ci (small σi
2
) the thresholds τijk get highly 
concentrated around a value representing reporting of symptoms associated 
with latent symptom propensity αij and episode intensity βik such that 
h(αij,βik)> τ*i with τ*i approaching a constant value as σi tends to zero.  
 
 
 
Figure 1: (a) Example of a J × K symptom matrix (J = number of symptoms; K = number of episodes) for 
subject 6010 with symptoms 1-26 listed vertically and hypoglycaemic episodes listed horizontally. Each 
reported symptom is marked with a square. (b) Rearrangement of the matrix rows and columns so that 
rows now appear according to frequency with which symptoms are experienced and columns according to 
the number of symptoms per episode (both following a descending order from the top-left corner) 
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We use a Bayesian approach (Berger, 1985) to estimate the posterior 
distribution of the unobserved latent factors and the variability of the 
thresholds. Posterior distributions of the latent variables are obtained using 
Markov chain Monte Carlo simulation techniques (Arminger and Muthen, 
1998). 
 
3.1 Thresholds in Model for Intra-Individual Consistency 
In earlier work (Zammitt et al, 2011) a multiplicative threshold form h(αij,βik) 
= αijβik was assumed with individual iexperiencing symptom j at episode k 
when τijk  ≤ h(αij,βik) = αijβik. In this paper, we also explore two other different 
thresholds to fit to this model. They are: (i) h(αij,βik) = αij + βi, and (ii) 
h(αij,βik) =  αij + βik + αijβik. The most appropriate threshold for the data in 
this analysis is chosen using the Deviance Information Criterion value of the 
corresponding model (Spiegelhalter et al., 2002). 
 
3.2 Grouped Symptoms 
To allow for an additional source of variation in the precision parameter, σi
−2
 
we categorised the symptoms into six distinct groups, three of which are 
discussed earlier (autonomic, neuroglycopenic, and general malaise). The 
three additional groups are: “autonomic/neuroglycopenic” for symptoms that 
are debatable as to which category they belong; “other symptoms” for 
symptoms that were not specified by patients in the report form; and “no 
symptom” when patients reported hypoglycaemia without experiencing any 
particular symptom. The group categorisation is shown in Table 1. This 
categorisation provides us with an additional source of variation that may 
arise from inherent differences between symptoms in different groups. 
 
To allow for group effects, the change made to the model presented in 
Section 3 relates to the prior for αij which corresponds to propensity of 
symptom j for patient i. Now, with each symptom being assigned to a 
specific group, we have αijl where l =1,…,6 indicates group, and we assume 
the following hierarchical prior: 
 
𝛼𝑖𝑗𝑙~ 𝐺𝑎𝑚𝑚𝑎 (𝜃,
𝜃
𝑢𝑙
) , 𝑙 = 1, … ,6 
giving 𝐸(𝛼𝑖𝑗𝑙) =  𝑢𝑙 ,  and𝑉𝑎𝑟(𝛼𝑖𝑗𝑙) =
𝑢𝑙
2
𝜃
, 𝑙 = 1, … ,6 
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The prior for ul is chosen to be relatively non-informative:  
 
ul ~ Gamma(αul,βul) with αul= 1 and βul= 1. To facilitate the convergence of 
the MCMC algorithm, we set θ to 1, but a non-informative prior  
θ~ Gamma(αθ,βθ) may also be assumed. 
 
3.3 Patient Consistency Results 
Threshold τijk ≤ αijβik  gives the lowest DIC value (DIC = 29003.1) indicating 
that it is the most suitable threshold to fit the consistency model. Therefore, 
all results discussed here are based on this threshold. Analysing the episodes 
of hypoglycaemia with the symptoms being grouped gives slightly different 
consistency estimates for some of the subjects, as compared to the analysis 
in Zammitt et al (2011). With grouped symptoms, the consistency values 
estimated from this model range from 16.15 (subject 2013) to 95.35 (subject 
1028) with standard deviation 2.055 and 2.407 respectively. The distribution 
of the mean consistency estimates under the two models is shown in Figure 
2. 
 
 
Figure 2: Histogram of estimated consistency parameter ?̃?𝑖
2= 100/(1+ σi
2)for model without grouped-
symptoms (left), and for model with grouped-symptoms (right). 
 
Figure 3 (Left) shows the ranking of patients’ consistency with  the grouped 
symptoms model (Section 3.2) versus their ranking with the model not using 
grouping (Section 3). Patients are ranked in descending order based on their 
consistency estimates starting from the highest estimates to the lowest. It is 
noticeable that a number of subjects have obvious changes in their ranking. 
Under the grouped symptoms model, patients 6018 and 5009 have increased 
consistency estimates (from low consistency rank 53 and 56, to higher rank 
33 and 26 respectively). Similarly considerable changes are observed in 
patients’ 4008 and 6002 ranking, while patient 6065 appears to move 
towards the opposite direction with the grouped-symptoms model resulting 
in lower consistency. 
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Figure 3 (Right) shows the posterior densities of mean propensity for each 
group,𝑢𝑙. These densities demonstrate that groups have distinct propensity 
mean. The “No symptom” group shows highest variability since it is less 
frequently reported by patients in this study. 
 
Figure 3: (Left) Graph shows descending order for ranking of consistency estimates, ?̃?𝑖   of 59 patients 
for model with grouped symptoms versus model without grouped symptoms. (Right) Distributions of 
posterior group propensity, 𝑢𝑙 
 
4. Association Between Consistency and Patient-Specific 
Covariates 
We now investigate the effect of ten patient-specific covariates on 
patients’ symptom reporting consistency. Zammit et al. (2011) explored the 
main effects of such covariates, and we extend this by also considering a 
number of interactions between them. The 10 covariates described in Section 
2 are used in the analysis. Type of diabetes (1 or 2) and retinopathy (no 
retinopathy RET1, background retinopathy RET2 and proliferative 
retinopathy RET3) are considered as categorical while other covariates are in 
numerical form. Hypoglycaemiais measured on a scale 1 to 7, with higher 
scores corresponding to weaker awareness of hypoglycaemia. 
 
Aiming to establish whether or not the effect on consistency of one 
factor is the same at all levels of other factors, we also consider the 
following possible interactions between covariates: interactions of gender 
with type of diabetes, duration, awareness, BMI, and retinopathy; 
interactions of C-peptide with duration and type of diabetes; interactions of 
awareness with age, duration, and type, and interaction between duration and 
retinopathy. These specific interactions were suggested as the most 
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meaningful combinations based on anecdotal evidence in the area. In a GLM 
setting we assume 
?̃?𝑖~ 𝐺𝑎𝑚𝑚𝑎 (λ,
𝜆
𝑚𝑖
)for𝑖 = 1, … ,59 
 
so we have 𝐸(?̃?𝑖) =  𝑚𝑖  and 𝑣𝑎𝑟(?̃?𝑖) =  
𝑚𝑖
2
𝜆
. Parameter mi is the mean 
consistency response and linked to all patient-specific covariates through 
function mi = exp(xi
T
,b) where i=1,2,…,I and b = (b0,b1,…,bp)
T
 is a vector of 
coefficient corresponding to the vector of covariates 
𝑥𝑖
𝑇 = (1, 𝑥1,𝑖 , 𝑥2,𝑖, … , 𝑥𝑝,𝑖), as shown in detail in the linear predictor equation 
below: 
 
log{𝐸(𝑚𝑖)} = 𝑏0 +  𝑏𝑔𝑒𝑛𝐺𝐸𝑁𝑖 + 𝑏𝑎𝑔𝑒𝐴𝐺𝐸𝑖 +  𝑏𝑡𝑦𝑝𝑒𝑇𝑌𝑃𝐸𝑖 +  𝑏𝑑𝑢𝑟𝐷𝑈𝑅𝑖
+ 𝑏𝑟𝑒𝑡1𝑅𝐸𝑇1𝑖 +  𝑏𝑟𝑒𝑡2𝑅𝐸𝑇2𝑖 +  𝑏𝑟𝑒𝑡3𝑅𝐸𝑇3𝑖 +  𝑏𝑎𝑤𝑎𝑟𝐴𝑊𝐴𝑅𝑖
+ 𝑏𝑏𝑚𝑖𝐵𝑀𝐼𝑖 +  𝑏𝑐𝑝𝑒𝑝𝐶𝑃𝐸𝑃𝑖 +  𝑏ℎ𝑏𝑎𝐻𝐵𝐴𝑖 +  𝑏𝑎𝑐𝑒𝐴𝐶𝐸𝑖
+ 𝑏𝑔𝑒𝑛𝑋𝑡𝑦𝑝𝑒(𝐺𝐸𝑁. 𝑇𝑌𝑃𝐸)𝑖 + 𝑏𝑔𝑒𝑛𝑋𝑑𝑢𝑟(𝐺𝐸𝑁. 𝐷𝑈𝑅)𝑖
+ 𝑏𝑔𝑒𝑛𝑋𝑎𝑤𝑎𝑟(𝐺𝐸𝑁. 𝐴𝑊𝐴𝑅)𝑖 +  𝑏𝑔𝑒𝑛𝑋𝑏𝑚𝑖(𝐺𝐸𝑁. 𝐵𝑀𝐼)𝑖
+ 𝑏𝑐𝑝𝑒𝑝𝑋𝑑𝑢𝑟(𝐶𝑃𝐸𝑃. 𝐷𝑈𝑅)𝑖 + 𝑏𝑐𝑝𝑒𝑝𝑋𝑡𝑦𝑝𝑒(𝐶𝑃𝐸𝑃. 𝑇𝑌𝑃𝐸)𝑖
+ 𝑏𝑎𝑤𝑎𝑟𝑋𝑎𝑔𝑒(𝐴𝑊𝐴𝑅. 𝐴𝐺𝐸)𝑖 +  𝑏𝑎𝑤𝑎𝑟𝑋𝑑𝑢𝑟(𝐴𝑊𝐴𝑅. 𝐷𝑈𝑅)𝑖
+ 𝑏𝑎𝑤𝑎𝑟𝑋𝑡𝑦𝑝𝑒(𝐴𝑊𝐴𝑅. 𝑇𝑌𝑃𝐸)𝑖 + 𝑏𝑑𝑢𝑟𝑋𝑟𝑒𝑡1(𝐷𝑈𝑅. 𝑅𝐸𝑇1)𝑖
+ 𝑏𝑑𝑢𝑟𝑋𝑟𝑒𝑡2(𝐷𝑈𝑅. 𝑅𝐸𝑇2)𝑖 + 𝑏𝑑𝑢𝑟𝑋𝑟𝑒𝑡3(𝐷𝑈𝑅. 𝑅𝐸𝑇3)𝑖
+ 𝑏𝑔𝑒𝑛𝑋𝑟𝑒𝑡1(𝐺𝐸𝑁. 𝑅𝐸𝑇1)𝑖 + 𝑏𝑔𝑒𝑛𝑋𝑟𝑒𝑡2(𝐺𝐸𝑁. 𝑅𝐸𝑇2)𝑖
+ 𝑏𝑔𝑒𝑛𝑋𝑟𝑒𝑡3(𝐺𝐸𝑁. 𝑅𝐸𝑇3)𝑖 
 
where GEN represents gender, DUR represents duration, RET1 represents 
no retinopathy, RET2 represents background retinopathy, RET3 represents 
proliferative retinopathy, AWAR represents awareness of hypoglycaemia, 
BMI represents body mass index, CPEP represents C-peptide, HBA 
represents haemoglobin A1c, and ACE represents angiotensin converting 
enzyme. 
 
All b = 1,…,p are assumed to have normal distribution priors and the prior 
for λ is inverse-gamma: 
 
𝑏𝑝~ 𝑁𝑜𝑟𝑚𝑎𝑙 (μbp , σbp)whereμbp  = 0, σbp = 10
4 
𝜆~ 𝐼𝑛𝑣𝑒𝑟𝑠𝑒 − 𝑔𝑎𝑚𝑚𝑎(γλ, δλ)where γλ = δλ= 10−
3 
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4.1   Results on patients characteristics effects 
Figure 4 summaries the Bayesian estimation for all coefficients in the model 
without grouped symptoms (left) and in the model with grouped symptoms 
(right). When symptoms are not grouped, the Bayesian intervals for bgen and 
bawar exclude zero indicating that these two covariates have significant 
effects on consistency. The estimate of bawar is 0.1362 implying that subjects 
with lower awareness recorded lower variability in their symptoms than 
those with higher awareness. With grouped symptoms, gender is the only 
factor affecting consistency of symptom reporting (gender was coded as 
males = 0, females = 1). Female subjects appear to have lower consistency 
than their opposite gender, with bgen = −0.7986 (95% Bayesian interval 
−1.264, −0.3354). 
 
Examination on what effect covariates and their interactions have on 
consistency estimates (Figure 5) reveals that female subjects are less 
consistent than male subjects. Although the mean for gender coefficient was 
positive, bgen = 0.7855 (95% BI 0.0894, 1.479), if we take into account the 
overall effect of gender, the consistency of female patients (mean = 0.6488, 
95% BI 0.3325, 1.2761) is significantly lower than that of male patients 
(mean = 5.2331, 95% BI 2.2412, 12.025). The ratio of female to male 
consistency is 0.14 (95% BI 0.0449, 0.3366).  
 
The posterior mean of the coefficients for type and age are btype = −1.159 
(95% BI −2.616,−1.0715) and bage = 0.6291 (95% BI 0.1921, 1.1100) 
respectively, indicating that patients with diabetes Type 2 are less consistent 
than Type 1 patients (type was coded as type 1 = 0, type 2 = 1), and older 
subjects are more consistent than younger subjects. C-peptide is another 
factor that appears to have a systematic negative effect on consistency. 
 
The analysis also suggests a number of significant interactions on the effect 
of patient characteristics on their symptom consistency. These include the 
interactions of awareness with age, duration and type, meaning that when 
patients with different level of awareness have different profiles regarding 
age, duration or type of diabetes, their consistency when reporting 
hypoglycaemia symptoms vary. The mean of the coefficient for interaction 
between awareness and type of diabetes is bawarXtype = 0.8105 suggesting that 
as the awareness score increases (implying impaired awareness), diabetes 
Type 1 patients have lower  consistency while for patients with diabetes 
Type 2, consistency increases as awareness score increases. 
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Figure 4: Posterior means (bullets) and 95% equal-tailed Bayesian intervals (bars) for standardised 
coefficients of patients-specific covariates for model without grouped-symptoms (left); and for model 
with grouped-symptoms (right). 
 
 
Figure 5: Posterior means (bullets) and 95% equal-tailed Bayesian intervals (bars) for standardised 
coefficients of patient-specific covariates and their interaction terms for model without 
groupedsymptoms. 
 
5. Predictive Model 
We apply variable selection through stepwise regression to determine 
which covariates are important and should be included in a predictive model. 
Stepwise regression will add or remove one variable at a time, given that the 
variable meets a selection criterion for entry or removal, until a stable set is 
obtained. The selection criterion used in this analysis is the Deviance 
Information Criterion (DIC). To run the procedure, we incorporate a binary 
vector γ = (γ1, γ2,…,γp), where p is number of covariates, to the linear 
predictor. We have wi= σi
-2 
and 
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𝑤𝑖~ 𝐺𝑎𝑚𝑚𝑎 (λ,
𝜆
𝑚𝑖
),   for 𝑖 = 1, … ,59 
log(𝑚𝑖) =  𝛽0 + 𝛽1𝛾1𝑋1 +  𝛽2𝛾2𝑋2 + ⋯ +  𝛽𝑝𝛾𝑝𝑋𝑝. 
 
In each step, we fit p models and estimate DIC values. The procedure is 
terminated when the selected model is the same as the one indicated in the 
previous cycle of procedure (Ntzoufras, 2011). 
 
5.1  Variable selection results 
Stepwise regression for the model without grouped-symptoms containing ten 
covariates gives a  predictive model  which includes covariates gender, 
retinopathy, duration, haemoglobin A1c, and awareness of hypoglycaemia 
(DIC=151.40). When we also consider interactions between covariates, the 
best predictive model (DIC=134.213) includes covariates gender, duration of 
diabetes, retinopathy, C-peptide, haemoglobin A1c and awareness,and 
interactions between gender  ×  duration, gender ×   awareness, gender ×  
retinopathy, C-peptide ×  duration, C-peptide ×  type, awareness ×  type, 
and awareness ×  duration. 
 
6. Conclusions 
The analysis in this paper extends previous research on individual 
consistency of hypoglycaemic symptom reporting by considering different 
functional forms of symptom experiencing thresholds, allowing for 
additional variation arising from grouping of symptoms, and performing 
variable selection to determine a predictive model for the effect of patient 
characteristics and their interactions on symptom consistency. Although this 
is not a large-scale study, the results provide useful insight on the 
consistency of individuals when reporting hypoglycaemic symptoms 
throughout a series of episodes.  
 
Our work shows that a multiplicative form of symptom propensity and 
episode intensity provides the most suitable symptom experiencing threshold 
for the data in this study. Allowing additional variation in the model, by 
considering symptoms grouped in six categories based mainly on their 
physiological features, reveals that groups of symptoms show distinct 
propensity and that subjects’ gender has significant impact on the 
consistency of symptom reporting. This agrees with earlier findings where 
gender and awareness appear to significantly affect symptom variability.  
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Variable selection was   performed on the model without grouped 
symptoms model, since this appeared to fit the data better, based on a lower 
DIC value. When we consider the interactions between covariates, the 
variable selection results suggest that gender, C-peptide and retinopathy 
which are statistically significant characteristics should be in our predictive 
model. The predictive model also includes interactions between gender and 
duration, awareness and retinopathy. 
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